Hester Biosciences Limited Receives Requests for Reclassification of Promoters to Public Shareholders
Hester Biosciences Limited reported on May 15, 2026, the receipt of formal requests from two individuals to reclassify their shareholdings from the "Promoter" category to the "Public" category. The requests were submitted by Mr. Ravin Gandhi and Ms. Bela Gandhi.The request for reclassification is based on the individuals asserting that they no longer hold an association with the management or control of the Company, either directly or indirectly. The submitted declarations indicate that the shareholders are treating their holdings as purely passive investments, and they do not hold any key managerial positions or Board seats.
The following table summarizes the details of the shareholders who submitted the reclassification request:
| Shareholder Name | Shares Held (Equity) | Percentage of Total Voting Rights | Date of Request |
|---|---|---|---|
| Mr. Ravin Gandhi | 403,320 | 4.74% | May 14, 2026 |
| Ms. Bela Gandhi | 400,635 | 4.71% | May 14, 2026 |
In addition to the reclassification request, Mr. Ravin Gandhi’s declaration noted that he resigned from the Board of Directors of the Company vide a letter dated May 12, 2026.
The company stated that it is undertaking necessary steps to process these requests in accordance with applicable regulations.
HESTERBIO Stock Price Movement
Shares of Hester Biosciences Limited are surging as of 1:00 PM today, gaining ₹204.80 or 11.77% in live trading to reach ₹1945. The stock is showing robust momentum, with 130,783 shares turning over during the active session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.